100 N. Tucker Blvd.
St. Louis, MO 63101
United States
Saint Louis University - School of Law
SSRN RANKINGS
in Total Papers Downloads
Intellectual Property, Health, Vaccines, Preparedness, Outbreak, Pandemic, Zika, Ebola, Patent, Vaccine Development, Disease, Licensing, Dormant License, Inefficiency, Incentives, Transactional IP, Funding, R&D
Priority review voucher, Food and Drug Administration (FDA), 21st Century Cures Act, neglected diseases, Ebola, Zika, incentives
Vaccine, Zika, Army, outbreak, infectious disease, exclusivity, Patent Act, patent, technology transfer, public funding, public interest
vaccines, patents, health, intellectual property, outbreaks, infectious diseases, pandemics, public-private partnerships, Coalition for Epidemic Preparedness Innovations
TC Heartland v Kraft, Venue, Patent Venue, Patent Exceptionalism, Personal Jurisdiction, Eastern District of Texas, Supreme Court, Federal Circuit
vaccine, health, pathogen, outbreak, Salk, polio, patent, intellectual property, licensing, liability, property, Calabresi, Melamed, Reichman
Intellectual property, TRIPs, BRICs, Roadmap, Brazil, India, compulsory licensing
Coronavirus, COVID-19, vaccine, patent, intellectual property
Blockchain, Health, Data, Healthcare, Insurance Companies, Sweden, Estonia, Infrastructure
copyright, music, licensing, territoriality, collective rights management, European Commission, European law
coronavirus, COVID-19, China, World Health Organization, misinformation, disinformation, health law, health policy, Missouri, New York, Foreign Sovereignty Immunities Act
vaccines, intellectual property, property, Ebola, Zika, COVID-19, licensing, Oil States, liability
courts, judicialization, health, right to health, judicial review, Brazil, Colombia, Michigan, constitutional law
misinformation, coronavirus, pandemic, COVID-19, social media, Facebook, Pinterest, Youtube, Tik Tok, conspiracy theories, vaccines, patents, Bill Gates
patents, intellectual property, Venice, Italy, glass, glass industry, tailored regimes, Patent and Trademark Office, TRIPS Agreement
Coronavirus, COVID-19, vaccines, intellectual property, preparedness, patents, public-private partnerships, CEPI, patent pledge
patent, pharmaceutical industry, biologics, drugs, antitrust, competition, Food and Drug Administration, intellectual property, patent term, Humira, license, revocation
COVID-19, coronavirus, self-defense, necessity, lesser-evil, lesser harm, defense, privilege, intellectual property, IP, Lake Erie, Vincent v. Lake Erie, respirators, 3d printing, pharmaceuticals, public health, public necessity, private necessity, imminent harm, torts, common law, emergency
COVID-19, coronavirus, Portugal, state of emergency, state of calamity, constitutional law, immigration, migrants, religious holidays
vaccine, vaccination, hesitancy, staggering, vaccination schedules, alternative vaccination schedules, vaccine refusal, vaccine hesitancy, Centers for Disease Control and Prevention
COVID-19, coronavirus, SARS-CoV-2, pandemic, pharmaceuticals, vaccines, healthcare markets, incentives, for-profit, public health, innovation, remdesivir, Food and Drug Administration, FDA, Gilead, Ebola, SARS, MERS, preparedness, private public partnerships, PPPs, emergency response
vaccine, nationalism, COVID-19, coronavirus, pandemic, H1N1, swine flu, pre-production contracts, compulsory licensing, TRIPS Agreement, equitable access, vulnerable populations, United States, Germany
